Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Lucid Diagnostics (LUCD) Preferred Shares Issued (2023 - 2024)

Lucid Diagnostics (LUCD) has disclosed Preferred Shares Issued for 2 consecutive years, with $11.6 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Preferred Shares Issued changed N/A year-over-year to $11.6 million, compared with a TTM value of $29.8 million through Dec 2024, up 59.99%, and an annual FY2024 reading of $29.8 million, up 59.99% over the prior year.
  • Preferred Shares Issued was $11.6 million for Q2 2024 at Lucid Diagnostics, down from $18.2 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $18.2 million in Q1 2024 and bottomed at $5.0 million in Q4 2023.